Edwards Historical Income Statement
EW Stock | USD 90.21 0.13 0.14% |
Historical analysis of Edwards Lifesciences income statement accounts such as Selling General Administrative of 1.8 B can show how well Edwards Lifesciences Corp performed in making a profits. Evaluating Edwards Lifesciences income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Edwards Lifesciences's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Edwards Lifesciences Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Edwards Lifesciences Corp is a good buy for the upcoming year.
Edwards |
About Edwards Income Statement Analysis
Edwards Lifesciences Corp Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Edwards Lifesciences shareholders. The income statement also shows Edwards investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Edwards Lifesciences Income Statement Chart
Edwards Lifesciences Corp Income Statement is one of the three primary financial statements used for reporting Edwards's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Edwards Lifesciences Corp revenue and expense. Edwards Lifesciences Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Edwards Lifesciences' Income Before Tax is fairly stable compared to the past year. Total Other Income Expense Net is likely to climb to about 67.2 M in 2024, whereas Interest Expense is likely to drop slightly above 10.6 M in 2024. Add Fundamental
Total Revenue
Total revenue comprises all receipts Edwards Lifesciences Corp generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Edwards Lifesciences Corp minus its cost of goods sold. It is profit before Edwards Lifesciences operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Edwards Lifesciences Corp. It is also known as Edwards Lifesciences overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from Edwards Lifesciences' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Edwards Lifesciences Corp current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edwards Lifesciences Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing. At this time, Edwards Lifesciences' Income Before Tax is fairly stable compared to the past year. Total Other Income Expense Net is likely to climb to about 67.2 M in 2024, whereas Interest Expense is likely to drop slightly above 10.6 M in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 4.0B | 4.3B | 4.6B | 4.9B | Total Revenue | 5.2B | 5.4B | 6.0B | 6.3B |
Edwards Lifesciences income statement Correlations
Click cells to compare fundamentals
Edwards Lifesciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Edwards Lifesciences income statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Depreciation And Amortization | 183.8M | 107.2M | 134.8M | 81.4M | 144.9M | 83.4M | |
Interest Expense | 20.7M | 15.8M | 18.4M | 19.2M | 17.6M | 10.6M | |
Selling General Administrative | 1.2B | 1.2B | 1.5B | 1.6B | 1.8B | 1.8B | |
Total Revenue | 4.3B | 4.4B | 5.2B | 5.4B | 6.0B | 6.3B | |
Gross Profit | 3.2B | 3.3B | 4.0B | 4.3B | 4.6B | 4.9B | |
Other Operating Expenses | 3.1B | 3.1B | 3.6B | 3.6B | 4.3B | 4.5B | |
Operating Income | 1.1B | 1.6B | 1.3B | 1.7B | 1.5B | 1.6B | |
Ebit | 1.1B | 1.6B | 1.3B | 1.7B | 1.5B | 1.6B | |
Research Development | 752.7M | 760.7M | 903.1M | 945.2M | 1.1B | 1.1B | |
Ebitda | 1.3B | 1.7B | 1.5B | 1.8B | 1.5B | 1.6B | |
Cost Of Revenue | 1.1B | 1.1B | 1.2B | 1.1B | 1.4B | 697.9M | |
Total Operating Expenses | 2.0B | 2.0B | 2.4B | 2.5B | 2.9B | 3.0B | |
Income Before Tax | 1.2B | 916.7M | 1.7B | 1.8B | 1.6B | 1.7B | |
Total Other Income Expense Net | 19.7M | (711.7M) | 353.5M | 18.9M | 64M | 67.2M | |
Net Income | 1.0B | 823.4M | 1.5B | 1.5B | 1.4B | 1.5B | |
Income Tax Expense | 119.6M | 93.3M | 198.9M | 245.5M | 198.7M | 113.1M | |
Net Income Applicable To Common Shares | 1.0B | 823.4M | 1.5B | 1.5B | 1.8B | 1.8B | |
Net Income From Continuing Ops | 1.0B | 823.4M | 1.5B | 1.5B | 1.4B | 836.3M | |
Non Recurring | 98M | 405.4M | 20.6M | 76.5M | 88.0M | 92.4M | |
Non Operating Income Net Other | 40.4M | 34.9M | 30.1M | 38.1M | 43.8M | 46.0M | |
Tax Provision | 119.6M | 93.3M | 198.9M | 245.5M | 207.6M | 201.8M | |
Net Interest Income | 11.5M | 7.6M | (1M) | 16.3M | 40.7M | 42.7M | |
Interest Income | 32.2M | 7.6M | 1M | 16.3M | 67.2M | 70.6M | |
Reconciled Depreciation | 89.3M | 107.2M | 134.8M | 139.6M | 143.6M | 121.6M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Edwards Lifesciences Corp is a strong investment it is important to analyze Edwards Lifesciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Edwards Lifesciences' future performance. For an informed investment choice regarding Edwards Stock, refer to the following important reports:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edwards Lifesciences Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for Edwards Stock analysis
When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.
Stocks Directory Find actively traded stocks across global markets | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |
Is Edwards Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Edwards Lifesciences. If investors know Edwards will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Edwards Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.036 | Earnings Share 2.32 | Revenue Per Share 10.151 | Quarterly Revenue Growth 0.095 | Return On Assets 0.1205 |
The market value of Edwards Lifesciences Corp is measured differently than its book value, which is the value of Edwards that is recorded on the company's balance sheet. Investors also form their own opinion of Edwards Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Edwards Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Edwards Lifesciences' market value can be influenced by many factors that don't directly affect Edwards Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Edwards Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Edwards Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Edwards Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.